Messages from Johns Hopkins All the proceeds we raise are donated to the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medical Center for cancer research. Below are just a sampling of the thank you letters received for money contributed to this valuable effort. From Edward D. Miller, MD The Frances Watt Baker, MD and Lenox D. Baker, Jr., MD Dean of the Medical Faculty Chief Executive Officer January 28, 2009 As Dean of the School of Medicine, I am pleased to know that the Run for Kathy, along with other friends of the school, supports our mission. The organization’s gift to benefit cancer research enables patients who visit the Sidney Kimmel Comprehensive Cancer Center to have access to some of the most innovative and advanced therapies in the world. Because Center clinicians and research scientists work closely together, new drugs and treatments developed in the laboratory are quickly transferred to the clinical setting, offering patients improved therapeutic options. Philanthropy is a fundamental component in Johns Hopkins Medicine’s ability to have the resources necessary to maintain its place as a world leader in teaching, research, and patient care, and we are especially appreciative of the organization’s continued support during these difficult economic times. With Run for Kathy’s participation, we are ensuring the School of Medicine successfully continues as one of the nation’s top institutions, demonstrating an exemplary record of achievement and performance. From William Nelson, MD, Ph.D. Marion I. Knott Director and Professor of Oncology January 26, 2009 At a time when you were remembering someone dear to you, you extended your generosity and thoughtfulness to those still on the forefront of cancer research and treatment. On their behalf, thank you. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is grateful for your recent gift to support cancer research. Since its inception the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins has been dedicated to better understanding human cancers and finding more effective treatments. Our Cancer Center clinicians and research scientists work closely together finding new drugs and treatments that can be developed in the laboratory and quickly transferred to the clinical setting, offering patients improved therapeutic options. Your support makes these advancements possible. We extend our gratitude to you for being our partner in turning our research into results. Through your support, you are a valued member of our team and we welcome your further involvement with the Kimmel Cancer Center. From Kyleigh Helfrich Associate Director of Development at the Sidney Kimmel Cancer Center October 13, 2007 Good morning and thank you all so much for supporting the 9th Annual Run for Kathy. My name is Kyleigh Helfrich and I am the Associate Director of Development at the Sidney Kimmel Cancer Center at Johns Hopkins. It is truly an honor to speak to you all today. This is a wonderful way to honor Kathy’s memory and to be proactive in the fight against cancer. To date, you have raised over $77,000 and I have no doubt that you will make your $100,000 goal. Every dollar that you have raised has gone to researching better prevention methods, treatment of and vaccines for cervical cancer. We are relying more heavily on the generosity of individuals like you to make up for the decreased availability of federal research funds because of budget cuts. Each year there are 13,000 women diagnosed with cervical cancer in the United States. At the Kimmel Cancer Center we are striving to dramatically reduce this number. There are several things that Kimmel researchers have done in the last year that we believe will dramatically reduce that number. The first is the Human Papillomavirus (HPV) vaccine, this virus is linked to many cases of cervical cancer. This vaccine is a new weapon against future cases. The second is prevention and early diagnosis. We have dedicated a new scholarship program called the Dr. Abeloff Scholars Program in Cancer Prevention and Control – it will support faculty scholars and scholars-in-training as they study the causes and risk factors for cancer in healthy populations and develop new approaches to cancer risk reduction and prevention. The third is clinical trails. We currently have 12 clinical trials underway in identifying new methods of treatment for cervical cancer. These are experimental methods that we hope will open new doors to a cure. Thank you again for your support of the Kimmel Cancer Center at Johns Hopkins and for helping us fight cancer. ___________________________________________________________